

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | skeletal muscle adaptation (GO:0043501) | 8.61807181 |
| 2 | skeletal muscle fiber development (GO:0048741) | 8.31394635 |
| 3 | * actin filament-based movement (GO:0030048) | 8.01523606 |
| 4 | myotube cell development (GO:0014904) | 7.04576729 |
| 5 | striated muscle contraction (GO:0006941) | 6.85785248 |
| 6 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 6.65943148 |
| 7 | cytidine deamination (GO:0009972) | 6.56739731 |
| 8 | cytidine metabolic process (GO:0046087) | 6.56739731 |
| 9 | cytidine catabolic process (GO:0006216) | 6.56739731 |
| 10 | sarcomere organization (GO:0045214) | 6.51812635 |
| 11 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.34789311 |
| 12 | creatine metabolic process (GO:0006600) | 6.20240530 |
| 13 | skeletal muscle tissue regeneration (GO:0043403) | 6.08276070 |
| 14 | myofibril assembly (GO:0030239) | 5.98018271 |
| 15 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 5.94676501 |
| 16 | * muscle contraction (GO:0006936) | 5.76792170 |
| 17 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 5.74882724 |
| 18 | * plasma membrane repair (GO:0001778) | 5.67470061 |
| 19 | carnitine shuttle (GO:0006853) | 5.64971029 |
| 20 | glycogen catabolic process (GO:0005980) | 5.42432466 |
| 21 | regulation of cell communication by electrical coupling (GO:0010649) | 5.42142054 |
| 22 | response to muscle activity (GO:0014850) | 5.34959556 |
| 23 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.30818438 |
| 24 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.27341057 |
| 25 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.18043102 |
| 26 | NADH metabolic process (GO:0006734) | 5.14789329 |
| 27 | muscle fiber development (GO:0048747) | 5.11825187 |
| 28 | * muscle system process (GO:0003012) | 5.08952615 |
| 29 | response to inactivity (GO:0014854) | 5.07666371 |
| 30 | glucan catabolic process (GO:0009251) | 5.07540158 |
| 31 | purine nucleotide salvage (GO:0032261) | 4.98896917 |
| 32 | glycogen biosynthetic process (GO:0005978) | 4.88893972 |
| 33 | glucan biosynthetic process (GO:0009250) | 4.88893972 |
| 34 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.85306826 |
| 35 | fatty acid transmembrane transport (GO:1902001) | 4.83710971 |
| 36 | striated muscle adaptation (GO:0014888) | 4.81216755 |
| 37 | fructose metabolic process (GO:0006000) | 4.72951287 |
| 38 | regulation of actin filament-based movement (GO:1903115) | 4.71835463 |
| 39 | cellular polysaccharide catabolic process (GO:0044247) | 4.71715327 |
| 40 | actomyosin structure organization (GO:0031032) | 4.67070201 |
| 41 | striated muscle atrophy (GO:0014891) | 4.61836660 |
| 42 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.59849545 |
| 43 | cardiac muscle hypertrophy (GO:0003300) | 4.55285823 |
| 44 | polysaccharide catabolic process (GO:0000272) | 4.49741137 |
| 45 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 4.40864624 |
| 46 | regulation of cofactor metabolic process (GO:0051193) | 4.38592825 |
| 47 | regulation of coenzyme metabolic process (GO:0051196) | 4.38592825 |
| 48 | IMP metabolic process (GO:0046040) | 4.35992524 |
| 49 | striated muscle hypertrophy (GO:0014897) | 4.34708092 |
| 50 | regulation of relaxation of muscle (GO:1901077) | 4.31765426 |
| 51 | gluconeogenesis (GO:0006094) | 4.26317842 |
| 52 | muscle cell fate commitment (GO:0042693) | 4.21489554 |
| 53 | tricarboxylic acid cycle (GO:0006099) | 4.20283343 |
| 54 | carnitine transmembrane transport (GO:1902603) | 4.19543058 |
| 55 | regulation of skeletal muscle cell differentiation (GO:2001014) | 4.19500469 |
| 56 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 4.19267401 |
| 57 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.15269658 |
| 58 | glycogen metabolic process (GO:0005977) | 4.00984525 |
| 59 | muscle atrophy (GO:0014889) | 4.00143846 |
| 60 | muscle organ development (GO:0007517) | 3.99050291 |
| 61 | muscle cell cellular homeostasis (GO:0046716) | 3.96708247 |
| 62 | muscle structure development (GO:0061061) | 3.94273387 |
| 63 | cellular glucan metabolic process (GO:0006073) | 3.92918073 |
| 64 | glucan metabolic process (GO:0044042) | 3.92918073 |
| 65 | muscle adaptation (GO:0043500) | 3.90907933 |
| 66 | muscle hypertrophy (GO:0014896) | 3.88381143 |
| 67 | striated muscle cell development (GO:0055002) | 3.86355478 |
| 68 | skeletal muscle tissue development (GO:0007519) | 3.86070595 |
| 69 | cardiac muscle contraction (GO:0060048) | 3.85222587 |
| 70 | muscle organ morphogenesis (GO:0048644) | 3.84908957 |
| 71 | carnitine transport (GO:0015879) | 3.83398283 |
| 72 | amino-acid betaine transport (GO:0015838) | 3.83398283 |
| 73 | hexose biosynthetic process (GO:0019319) | 3.81673860 |
| 74 | muscle tissue morphogenesis (GO:0060415) | 3.80046573 |
| 75 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.78166936 |
| 76 | myotube differentiation (GO:0014902) | 3.75149424 |
| 77 | neuronal action potential propagation (GO:0019227) | 3.73933373 |
| 78 | regulation of myoblast differentiation (GO:0045661) | 3.69365943 |
| 79 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.64888036 |
| 80 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.64888036 |
| 81 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.62935649 |
| 82 | negative regulation of muscle hypertrophy (GO:0014741) | 3.62697291 |
| 83 | regulation of sulfur metabolic process (GO:0042762) | 3.60733566 |
| 84 | adult heart development (GO:0007512) | 3.57864438 |
| 85 | cardiac myofibril assembly (GO:0055003) | 3.57503321 |
| 86 | cellular carbohydrate catabolic process (GO:0044275) | 3.57361070 |
| 87 | positive regulation of myotube differentiation (GO:0010831) | 3.54701361 |
| 88 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.53537609 |
| 89 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.48641097 |
| 90 | myoblast fusion (GO:0007520) | 3.42621873 |
| 91 | ubiquinone biosynthetic process (GO:0006744) | 3.41942973 |
| 92 | striated muscle tissue development (GO:0014706) | 3.38642592 |
| 93 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.37780960 |
| 94 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.37780960 |
| 95 | neuromuscular synaptic transmission (GO:0007274) | 3.36896524 |
| 96 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.36893956 |
| 97 | muscle hypertrophy in response to stress (GO:0003299) | 3.36893956 |
| 98 | cardiac muscle adaptation (GO:0014887) | 3.36893956 |
| 99 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.32211546 |
| 100 | negative regulation of protein localization to cell surface (GO:2000009) | 3.32018294 |
| 101 | negative regulation of muscle contraction (GO:0045932) | 3.29427751 |
| 102 | muscle cell development (GO:0055001) | 3.28644358 |
| 103 | relaxation of muscle (GO:0090075) | 3.28425940 |
| 104 | succinate metabolic process (GO:0006105) | 3.25604189 |
| 105 | IMP biosynthetic process (GO:0006188) | 3.24477423 |
| 106 | heart process (GO:0003015) | 3.24117484 |
| 107 | heart contraction (GO:0060047) | 3.24117484 |
| 108 | monosaccharide biosynthetic process (GO:0046364) | 3.24054607 |
| 109 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.23621734 |
| 110 | negative regulation of skeletal muscle tissue development (GO:0048642) | 3.23520763 |
| 111 | oxaloacetate metabolic process (GO:0006107) | 3.20932166 |
| 112 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.19857878 |
| 113 | regulation of striated muscle contraction (GO:0006942) | 3.14918517 |
| 114 | skeletal muscle cell differentiation (GO:0035914) | 3.14422014 |
| 115 | neuromuscular junction development (GO:0007528) | 3.13922605 |
| 116 | cardiac muscle cell development (GO:0055013) | 3.07456629 |
| 117 | positive regulation of myoblast differentiation (GO:0045663) | 3.07077663 |
| 118 | syncytium formation (GO:0006949) | 3.06288270 |
| 119 | * response to activity (GO:0014823) | 3.05451463 |
| 120 | 2-oxoglutarate metabolic process (GO:0006103) | 3.05240119 |
| 121 | syncytium formation by plasma membrane fusion (GO:0000768) | 3.04598233 |
| 122 | regulation of membrane repolarization (GO:0060306) | 3.03676448 |
| 123 | * muscle filament sliding (GO:0030049) | 13.1971508 |
| 124 | * actin-myosin filament sliding (GO:0033275) | 13.1971508 |
| 125 | skeletal muscle contraction (GO:0003009) | 11.8570820 |
| 126 | regulation of skeletal muscle contraction (GO:0014819) | 11.7382073 |
| 127 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 10.8005107 |
| 128 | * actin-mediated cell contraction (GO:0070252) | 10.7458893 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.68871779 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.68764475 |
| 3 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.59248256 |
| 4 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.47008618 |
| 5 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.39081678 |
| 6 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.94589377 |
| 7 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.78134916 |
| 8 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.78134916 |
| 9 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.52757121 |
| 10 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.44869320 |
| 11 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.36448485 |
| 12 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.11243085 |
| 13 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.02757963 |
| 14 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.99071205 |
| 15 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.98039557 |
| 16 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.93388399 |
| 17 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.90466352 |
| 18 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.89940966 |
| 19 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.89851205 |
| 20 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.83769717 |
| 21 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.73650630 |
| 22 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.70141745 |
| 23 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.64208183 |
| 24 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.60928635 |
| 25 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.58339941 |
| 26 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.58075231 |
| 27 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.56653324 |
| 28 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.56082664 |
| 29 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.55769306 |
| 30 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.52343805 |
| 31 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.50163351 |
| 32 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.49696316 |
| 33 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.48035843 |
| 34 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.47252477 |
| 35 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.44800563 |
| 36 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.41366517 |
| 37 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.38115325 |
| 38 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.37217916 |
| 39 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.36602036 |
| 40 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.36365212 |
| 41 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.32335436 |
| 42 | SA1_27219007_Chip-Seq_Bcells_Human | 1.30252338 |
| 43 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.25798596 |
| 44 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.24848910 |
| 45 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.19542164 |
| 46 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.19232093 |
| 47 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.18064072 |
| 48 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.15834914 |
| 49 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.13135471 |
| 50 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.12814610 |
| 51 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.12501691 |
| 52 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.11956687 |
| 53 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.11956687 |
| 54 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.11613977 |
| 55 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.11100222 |
| 56 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.10594465 |
| 57 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.09720629 |
| 58 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.09401714 |
| 59 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.08727314 |
| 60 | * OCT4_20526341_ChIP-Seq_ESCs_Human | 1.07704270 |
| 61 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.07433004 |
| 62 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.06866186 |
| 63 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.06649286 |
| 64 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.06441467 |
| 65 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.05933179 |
| 66 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.05863912 |
| 67 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.04995267 |
| 68 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.04497186 |
| 69 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.04229985 |
| 70 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.04129849 |
| 71 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.04050385 |
| 72 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.03395314 |
| 73 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.02903133 |
| 74 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.02456134 |
| 75 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.02099142 |
| 76 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.01843677 |
| 77 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.01461986 |
| 78 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.00707833 |
| 79 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99420565 |
| 80 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.99149914 |
| 81 | CJUN_26792858_Chip-Seq_BT549_Human | 0.98947504 |
| 82 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.98735322 |
| 83 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.96952411 |
| 84 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96003952 |
| 85 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.95582927 |
| 86 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.95405255 |
| 87 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.95175468 |
| 88 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.94849375 |
| 89 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.94719302 |
| 90 | P68_20966046_ChIP-Seq_HELA_Human | 0.94705650 |
| 91 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.92962462 |
| 92 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92724091 |
| 93 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.91834818 |
| 94 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.91682612 |
| 95 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.91608929 |
| 96 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.89978025 |
| 97 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.89672787 |
| 98 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.89672787 |
| 99 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.88455329 |
| 100 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.87973793 |
| 101 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.87963295 |
| 102 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.87686175 |
| 103 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.87396697 |
| 104 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.87176407 |
| 105 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.86713000 |
| 106 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.86695287 |
| 107 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.86621968 |
| 108 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.86150593 |
| 109 | ATF3_27146783_Chip-Seq_COLON_Human | 0.85788213 |
| 110 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.85164045 |
| 111 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.84963364 |
| 112 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.84949400 |
| 113 | CBP_21632823_ChIP-Seq_H3396_Human | 0.84393524 |
| 114 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.83813517 |
| 115 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.83382905 |
| 116 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.83291842 |
| 117 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.83152166 |
| 118 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.82287331 |
| 119 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.82242175 |
| 120 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.82122510 |
| 121 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.81762208 |
| 122 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.81754389 |
| 123 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.81705520 |
| 124 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.81641307 |
| 125 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81270091 |
| 126 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.78876318 |
| 127 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.77901442 |
| 128 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.77017309 |
| 129 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.75492695 |
| 130 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.74882887 |
| 131 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.74772747 |
| 132 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.74099628 |
| 133 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.73614815 |
| 134 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.73152244 |
| 135 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.73068332 |
| 136 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.70731721 |
| 137 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.69729076 |
| 138 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.69587349 |
| 139 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.68314185 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004145_abnormal_muscle_electrophysio | 7.47742366 |
| 2 | MP0000749_muscle_degeneration | 6.35981676 |
| 3 | MP0003646_muscle_fatigue | 6.32776995 |
| 4 | MP0000751_myopathy | 6.04856098 |
| 5 | MP0000747_muscle_weakness | 4.51512470 |
| 6 | MP0002106_abnormal_muscle_physiology | 4.17252853 |
| 7 | MP0004036_abnormal_muscle_relaxation | 3.94822635 |
| 8 | MP0000759_abnormal_skeletal_muscle | 3.77509822 |
| 9 | MP0002837_dystrophic_cardiac_calcinosis | 3.76029765 |
| 10 | MP0005369_muscle_phenotype | 3.49936158 |
| 11 | MP0004087_abnormal_muscle_fiber | 3.49074816 |
| 12 | MP0002269_muscular_atrophy | 3.39751484 |
| 13 | MP0000750_abnormal_muscle_regeneration | 3.26574695 |
| 14 | MP0004130_abnormal_muscle_cell | 3.21411219 |
| 15 | MP0005620_abnormal_muscle_contractility | 3.05171823 |
| 16 | MP0004233_abnormal_muscle_weight | 2.60218794 |
| 17 | MP0000733_abnormal_muscle_development | 2.51724508 |
| 18 | MP0002332_abnormal_exercise_endurance | 2.20479707 |
| 19 | MP0005330_cardiomyopathy | 2.15554602 |
| 20 | MP0002108_abnormal_muscle_morphology | 2.04508183 |
| 21 | MP0006036_abnormal_mitochondrial_physio | 1.89199438 |
| 22 | MP0004084_abnormal_cardiac_muscle | 1.87106493 |
| 23 | MP0004185_abnormal_adipocyte_glucose | 1.77369206 |
| 24 | MP0004484_altered_response_of | 1.73652421 |
| 25 | MP0004215_abnormal_myocardial_fiber | 1.65877098 |
| 26 | MP0005666_abnormal_adipose_tissue | 1.59264710 |
| 27 | MP0004270_analgesia | 1.54949865 |
| 28 | MP0000013_abnormal_adipose_tissue | 1.53359805 |
| 29 | MP0002971_abnormal_brown_adipose | 1.51542039 |
| 30 | MP0002972_abnormal_cardiac_muscle | 1.44729651 |
| 31 | MP0010630_abnormal_cardiac_muscle | 1.31075166 |
| 32 | MP0005375_adipose_tissue_phenotype | 1.26185591 |
| 33 | MP0003221_abnormal_cardiomyocyte_apopto | 1.22041950 |
| 34 | MP0003950_abnormal_plasma_membrane | 1.16588654 |
| 35 | MP0001661_extended_life_span | 1.08518429 |
| 36 | MP0003806_abnormal_nucleotide_metabolis | 1.06989284 |
| 37 | MP0005266_abnormal_metabolism | 1.03902782 |
| 38 | MP0001544_abnormal_cardiovascular_syste | 1.03896281 |
| 39 | MP0005385_cardiovascular_system_phenoty | 1.03896281 |
| 40 | MP0002822_catalepsy | 0.99970983 |
| 41 | MP0002234_abnormal_pharynx_morphology | 0.91547036 |
| 42 | MP0003705_abnormal_hypodermis_morpholog | 0.89017219 |
| 43 | MP0006035_abnormal_mitochondrial_morpho | 0.86647789 |
| 44 | MP0005275_abnormal_skin_tensile | 0.84159463 |
| 45 | MP0000003_abnormal_adipose_tissue | 0.83994755 |
| 46 | MP0004134_abnormal_chest_morphology | 0.78954828 |
| 47 | MP0003137_abnormal_impulse_conducting | 0.78713064 |
| 48 | MP0000762_abnormal_tongue_morphology | 0.70433005 |
| 49 | MP0000372_irregular_coat_pigmentation | 0.68728609 |
| 50 | MP0008961_abnormal_basal_metabolism | 0.68527502 |
| 51 | MP0001299_abnormal_eye_distance/ | 0.68208608 |
| 52 | MP0008775_abnormal_heart_ventricle | 0.66129334 |
| 53 | MP0000343_altered_response_to | 0.65951882 |
| 54 | MP0009250_abnormal_appendicular_skeleto | 0.62047177 |
| 55 | MP0003879_abnormal_hair_cell | 0.61048738 |
| 56 | MP0004043_abnormal_pH_regulation | 0.60205029 |
| 57 | MP0002078_abnormal_glucose_homeostasis | 0.59351197 |
| 58 | MP0006138_congestive_heart_failure | 0.58856713 |
| 59 | MP0004147_increased_porphyrin_level | 0.58605064 |
| 60 | MP0005670_abnormal_white_adipose | 0.58403158 |
| 61 | MP0003656_abnormal_erythrocyte_physiolo | 0.57978976 |
| 62 | MP0002127_abnormal_cardiovascular_syste | 0.54473939 |
| 63 | MP0000266_abnormal_heart_morphology | 0.54234263 |
| 64 | MP0005334_abnormal_fat_pad | 0.52703181 |
| 65 | MP0003045_fibrosis | 0.46917006 |
| 66 | MP0003828_pulmonary_edema | 0.46321118 |
| 67 | MP0010030_abnormal_orbit_morphology | 0.45446157 |
| 68 | MP0005452_abnormal_adipose_tissue | 0.45433629 |
| 69 | MP0005167_abnormal_blood-brain_barrier | 0.44956759 |
| 70 | MP0000579_abnormal_nail_morphology | 0.44697687 |
| 71 | MP0001346_abnormal_lacrimal_gland | 0.43925530 |
| 72 | MP0008569_lethality_at_weaning | 0.43563879 |
| 73 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.43271156 |
| 74 | MP0002896_abnormal_bone_mineralization | 0.42598035 |
| 75 | MP0002638_abnormal_pupillary_reflex | 0.39585328 |
| 76 | MP0005319_abnormal_enzyme/_coenzyme | 0.37138697 |
| 77 | MP0004510_myositis | 0.35980529 |
| 78 | MP0005423_abnormal_somatic_nervous | 0.35764520 |
| 79 | MP0009672_abnormal_birth_weight | 0.35553818 |
| 80 | MP0002796_impaired_skin_barrier | 0.33432542 |
| 81 | MP0005166_decreased_susceptibility_to | 0.33394383 |
| 82 | MP0002114_abnormal_axial_skeleton | 0.32070474 |
| 83 | MP0003959_abnormal_lean_body | 0.31454074 |
| 84 | MP0005451_abnormal_body_composition | 0.31386487 |
| 85 | MP0002734_abnormal_mechanical_nocicepti | 0.30776808 |
| 86 | MP0003948_abnormal_gas_homeostasis | 0.30636120 |
| 87 | MP0000230_abnormal_systemic_arterial | 0.30634065 |
| 88 | MP0004085_abnormal_heartbeat | 0.30627438 |
| 89 | MP0008438_abnormal_cutaneous_collagen | 0.30494108 |
| 90 | MP0005332_abnormal_amino_acid | 0.29906036 |
| 91 | MP0005083_abnormal_biliary_tract | 0.29057807 |
| 92 | MP0005535_abnormal_body_temperature | 0.28977218 |
| 93 | MP0003567_abnormal_fetal_cardiomyocyte | 0.27287052 |
| 94 | MP0002118_abnormal_lipid_homeostasis | 0.26633430 |
| 95 | MP0001853_heart_inflammation | 0.26392062 |
| 96 | MP0009115_abnormal_fat_cell | 0.26323159 |
| 97 | MP0001243_abnormal_dermal_layer | 0.25967315 |
| 98 | MP0001849_ear_inflammation | 0.25676789 |
| 99 | MP0002089_abnormal_postnatal_growth/wei | 0.24999146 |
| 100 | MP0005187_abnormal_penis_morphology | 0.24527252 |
| 101 | MP0005376_homeostasis/metabolism_phenot | 0.23475717 |
| 102 | MP0004858_abnormal_nervous_system | 0.22393859 |
| 103 | MP0002128_abnormal_blood_circulation | 0.22156087 |
| 104 | MP0004142_abnormal_muscle_tone | 0.20904156 |
| 105 | MP0001943_abnormal_respiration | 0.20781080 |
| 106 | MP0000383_abnormal_hair_follicle | 0.19861187 |
| 107 | MP0005165_increased_susceptibility_to | 0.18557954 |
| 108 | MP0005503_abnormal_tendon_morphology | 0.17124976 |
| 109 | MP0008770_decreased_survivor_rate | 0.16813715 |
| 110 | MP0009780_abnormal_chondrocyte_physiolo | 0.15848182 |
| 111 | MP0002066_abnormal_motor_capabilities/c | 0.15821441 |
| 112 | MP0003011_delayed_dark_adaptation | 0.15815429 |
| 113 | MP0005645_abnormal_hypothalamus_physiol | 0.15044499 |
| 114 | MP0002876_abnormal_thyroid_physiology | 0.14944531 |
| 115 | MP0002067_abnormal_sensory_capabilities | 0.14615700 |
| 116 | MP0003941_abnormal_skin_development | 0.13735798 |
| 117 | MP0006276_abnormal_autonomic_nervous | 0.13367178 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Type 1 muscle fiber predominance (HP:0003803) | 9.16687123 |
| 2 | Exercise-induced myalgia (HP:0003738) | 7.72061471 |
| 3 | Distal arthrogryposis (HP:0005684) | 7.10257948 |
| 4 | Myopathic facies (HP:0002058) | 6.77083715 |
| 5 | Exercise-induced muscle cramps (HP:0003710) | 6.75269808 |
| 6 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.25286911 |
| 7 | Calf muscle hypertrophy (HP:0008981) | 5.66613314 |
| 8 | Round ear (HP:0100830) | 5.65315513 |
| 9 | Ulnar deviation of the wrist (HP:0003049) | 5.50736650 |
| 10 | Muscle fiber splitting (HP:0003555) | 5.24921777 |
| 11 | Difficulty running (HP:0009046) | 5.01545034 |
| 12 | Hyporeflexia of lower limbs (HP:0002600) | 4.82813943 |
| 13 | Calcaneovalgus deformity (HP:0001848) | 4.80524715 |
| 14 | EMG: myopathic abnormalities (HP:0003458) | 4.62864490 |
| 15 | Myoglobinuria (HP:0002913) | 4.49616647 |
| 16 | Muscle stiffness (HP:0003552) | 4.41886153 |
| 17 | Absent phalangeal crease (HP:0006109) | 4.39947130 |
| 18 | Deformed tarsal bones (HP:0008119) | 4.38043547 |
| 19 | Abnormality of skeletal muscle fiber size (HP:0012084) | 4.19445237 |
| 20 | Increased connective tissue (HP:0009025) | 4.17660939 |
| 21 | Abnormality of the calf musculature (HP:0001430) | 4.00065232 |
| 22 | Neck muscle weakness (HP:0000467) | 3.98344250 |
| 23 | Rimmed vacuoles (HP:0003805) | 3.84358551 |
| 24 | Rhabdomyolysis (HP:0003201) | 3.77115120 |
| 25 | Myotonia (HP:0002486) | 3.71908766 |
| 26 | Abnormal finger flexion creases (HP:0006143) | 3.67830621 |
| 27 | Increased variability in muscle fiber diameter (HP:0003557) | 3.59018144 |
| 28 | Frequent falls (HP:0002359) | 3.56061289 |
| 29 | Areflexia of lower limbs (HP:0002522) | 3.23068191 |
| 30 | Subaortic stenosis (HP:0001682) | 3.22834460 |
| 31 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.22834460 |
| 32 | Difficulty climbing stairs (HP:0003551) | 3.18860336 |
| 33 | Malignant hyperthermia (HP:0002047) | 3.17583820 |
| 34 | Shoulder girdle muscle weakness (HP:0003547) | 3.02733911 |
| 35 | Pelvic girdle muscle weakness (HP:0003749) | 3.02665363 |
| 36 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.91754096 |
| 37 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.91754096 |
| 38 | Slender build (HP:0001533) | 2.90296426 |
| 39 | Progressive muscle weakness (HP:0003323) | 2.89930348 |
| 40 | Asymmetric septal hypertrophy (HP:0001670) | 2.88869629 |
| 41 | Abnormality of the calcaneus (HP:0008364) | 2.88275001 |
| 42 | Distal lower limb muscle weakness (HP:0009053) | 2.67654681 |
| 43 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.62819658 |
| 44 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.62262644 |
| 45 | Facial diplegia (HP:0001349) | 2.60334954 |
| 46 | EMG: neuropathic changes (HP:0003445) | 2.57023784 |
| 47 | Proximal amyotrophy (HP:0007126) | 2.56838343 |
| 48 | Hyperkalemia (HP:0002153) | 2.50575777 |
| 49 | Sudden death (HP:0001699) | 2.47573812 |
| 50 | Abnormality of the neuromuscular junction (HP:0003398) | 2.46610567 |
| 51 | Fatigable weakness (HP:0003473) | 2.46610567 |
| 52 | Hip contracture (HP:0003273) | 2.46321796 |
| 53 | Spinal rigidity (HP:0003306) | 2.41760063 |
| 54 | Bulbar palsy (HP:0001283) | 2.41340361 |
| 55 | Generalized muscle weakness (HP:0003324) | 2.39488077 |
| 56 | Scapular winging (HP:0003691) | 2.35465514 |
| 57 | Distal lower limb amyotrophy (HP:0008944) | 2.28225698 |
| 58 | Weak cry (HP:0001612) | 2.26259630 |
| 59 | Gowers sign (HP:0003391) | 2.24639088 |
| 60 | Muscular dystrophy (HP:0003560) | 2.21640896 |
| 61 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.19989998 |
| 62 | Paralysis (HP:0003470) | 2.17372666 |
| 63 | Limb-girdle muscle weakness (HP:0003325) | 2.14550606 |
| 64 | Fetal akinesia sequence (HP:0001989) | 2.12995800 |
| 65 | Limb-girdle muscle atrophy (HP:0003797) | 2.04103015 |
| 66 | Ulnar deviation of finger (HP:0009465) | 2.02959883 |
| 67 | Nonprogressive disorder (HP:0003680) | 2.01680788 |
| 68 | Waddling gait (HP:0002515) | 2.00749031 |
| 69 | * Muscle fiber inclusion bodies (HP:0100299) | 11.2779217 |
| 70 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 11.2779217 |
| 71 | Nemaline bodies (HP:0003798) | 11.0351835 |
| 72 | Hypoplastic ischia (HP:0003175) | 1.90469977 |
| 73 | Achilles tendon contracture (HP:0001771) | 1.83808003 |
| 74 | Metatarsus adductus (HP:0001840) | 1.81077130 |
| 75 | Heart block (HP:0012722) | 1.77926456 |
| 76 | Long clavicles (HP:0000890) | 1.76710668 |
| 77 | Lower limb amyotrophy (HP:0007210) | 1.72154656 |
| 78 | Ragged-red muscle fibers (HP:0003200) | 1.72087195 |
| 79 | Popliteal pterygium (HP:0009756) | 1.71699793 |
| 80 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.68570203 |
| 81 | Limited hip movement (HP:0008800) | 1.68364159 |
| 82 | Ventricular tachycardia (HP:0004756) | 1.68033289 |
| 83 | Abnormality of the Achilles tendon (HP:0005109) | 1.67812583 |
| 84 | Abnormal atrioventricular conduction (HP:0005150) | 1.66823277 |
| 85 | Abnormality of the ischium (HP:0003174) | 1.65901735 |
| 86 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.63793377 |
| 87 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.60109110 |
| 88 | Increased intramyocellular lipid droplets (HP:0012240) | 1.59835841 |
| 89 | Congenital hip dislocation (HP:0001374) | 1.56478811 |
| 90 | Dilated cardiomyopathy (HP:0001644) | 1.53323279 |
| 91 | Oligomenorrhea (HP:0000876) | 1.51592297 |
| 92 | Tarsal synostosis (HP:0008368) | 1.48700309 |
| 93 | Increased muscle lipid content (HP:0009058) | 1.46847694 |
| 94 | Lipoatrophy (HP:0100578) | 1.46218300 |
| 95 | Foot dorsiflexor weakness (HP:0009027) | 1.46155156 |
| 96 | Adducted thumb (HP:0001181) | 1.45973457 |
| 97 | Muscle fiber atrophy (HP:0100295) | 1.45771149 |
| 98 | Abnormality of the foot musculature (HP:0001436) | 1.45548090 |
| 99 | Ventricular arrhythmia (HP:0004308) | 1.44751901 |
| 100 | Bundle branch block (HP:0011710) | 1.33674852 |
| 101 | Cholelithiasis (HP:0001081) | 1.33454046 |
| 102 | Type 2 muscle fiber atrophy (HP:0003554) | 1.33285810 |
| 103 | Synostosis involving bones of the lower limbs (HP:0009138) | 1.33137163 |
| 104 | Synostosis involving bones of the feet (HP:0009140) | 1.33137163 |
| 105 | Steppage gait (HP:0003376) | 1.32706282 |
| 106 | Short palpebral fissure (HP:0012745) | 1.31716304 |
| 107 | Stridor (HP:0010307) | 1.28136516 |
| 108 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.28040370 |
| 109 | Easy fatigability (HP:0003388) | 1.27161871 |
| 110 | Abnormality of potassium homeostasis (HP:0011042) | 1.26244511 |
| 111 | Exercise intolerance (HP:0003546) | 1.25639102 |
| 112 | Abnormality of placental membranes (HP:0011409) | 1.25100383 |
| 113 | Amniotic constriction ring (HP:0009775) | 1.25100383 |
| 114 | Increased density of long bones (HP:0006392) | 1.22625510 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 7.75626983 |
| 2 | PIK3CG | 5.65785186 |
| 3 | PHKG1 | 5.19148631 |
| 4 | PHKG2 | 5.19148631 |
| 5 | NME1 | 4.29933562 |
| 6 | MAP2K3 | 3.33639417 |
| 7 | * OBSCN | 3.18436528 |
| 8 | NEK1 | 2.70943486 |
| 9 | MAP3K7 | 2.59033647 |
| 10 | PDK4 | 2.53066658 |
| 11 | PDK3 | 2.53066658 |
| 12 | PINK1 | 2.49350128 |
| 13 | DMPK | 2.40329700 |
| 14 | MUSK | 2.13579692 |
| 15 | TRIB3 | 2.08990263 |
| 16 | MAPK12 | 1.93045806 |
| 17 | MAP2K4 | 1.79584685 |
| 18 | PDK2 | 1.69357017 |
| 19 | BCKDK | 1.69356850 |
| 20 | MAP2K6 | 1.52634613 |
| 21 | PIK3CA | 1.39615987 |
| 22 | MAP3K3 | 1.32029133 |
| 23 | PKN2 | 1.07739265 |
| 24 | MARK1 | 1.05636608 |
| 25 | AKT2 | 1.00173441 |
| 26 | TAOK2 | 0.96141733 |
| 27 | MAPKAPK3 | 0.94162168 |
| 28 | PRKAA2 | 0.82985707 |
| 29 | MAPK11 | 0.81573009 |
| 30 | PRKAA1 | 0.81506863 |
| 31 | NEK9 | 0.79345357 |
| 32 | TAOK1 | 0.78493654 |
| 33 | MAP3K13 | 0.76871251 |
| 34 | ERBB3 | 0.73323131 |
| 35 | LIMK1 | 0.72958329 |
| 36 | CAMK2G | 0.71970249 |
| 37 | EPHB1 | 0.69112940 |
| 38 | MAP3K11 | 0.66761629 |
| 39 | ZAK | 0.65527931 |
| 40 | CAMK4 | 0.64836589 |
| 41 | TRPM7 | 0.61789858 |
| 42 | RIPK1 | 0.56534513 |
| 43 | STK24 | 0.51979930 |
| 44 | ILK | 0.47140727 |
| 45 | CAMK1 | 0.44682175 |
| 46 | CAMK2B | 0.43630673 |
| 47 | PTK6 | 0.42032328 |
| 48 | PKN1 | 0.39714470 |
| 49 | SIK1 | 0.38970036 |
| 50 | SGK1 | 0.38598086 |
| 51 | ROCK1 | 0.38041014 |
| 52 | TIE1 | 0.37512957 |
| 53 | TBK1 | 0.36868368 |
| 54 | EEF2K | 0.35928728 |
| 55 | PRKG1 | 0.35829507 |
| 56 | MAP3K6 | 0.34978020 |
| 57 | KSR2 | 0.34072428 |
| 58 | SGK2 | 0.33852047 |
| 59 | PRKACB | 0.31691444 |
| 60 | RPS6KB1 | 0.30828078 |
| 61 | MAPK4 | 0.30390573 |
| 62 | MAP3K5 | 0.30118748 |
| 63 | MAPK13 | 0.29056344 |
| 64 | MAP3K1 | 0.28247295 |
| 65 | RPS6KA3 | 0.28193414 |
| 66 | CDK19 | 0.25864937 |
| 67 | PRPF4B | 0.25209815 |
| 68 | PDPK1 | 0.25108831 |
| 69 | PRKD1 | 0.24866712 |
| 70 | MAP2K1 | 0.24169696 |
| 71 | PAK6 | 0.22445995 |
| 72 | PRKACA | 0.22260223 |
| 73 | MAPK7 | 0.21695219 |
| 74 | LATS1 | 0.21401154 |
| 75 | PDK1 | 0.21318060 |
| 76 | RPS6KB2 | 0.20964658 |
| 77 | MOS | 0.20615235 |
| 78 | ARAF | 0.20204490 |
| 79 | DAPK2 | 0.20072780 |
| 80 | TGFBR2 | 0.20067925 |
| 81 | INSRR | 0.19587587 |
| 82 | LATS2 | 0.19282397 |
| 83 | ICK | 0.19102622 |
| 84 | CAMK2D | 0.17170520 |
| 85 | FLT3 | 0.16139773 |
| 86 | MARK2 | 0.15997428 |
| 87 | CAMK1G | 0.14467886 |
| 88 | RPS6KC1 | 0.14186066 |
| 89 | RPS6KL1 | 0.14186066 |
| 90 | ZAP70 | 0.13859810 |
| 91 | BMX | 0.13842545 |
| 92 | SGK494 | 0.13372959 |
| 93 | SGK223 | 0.13372959 |
| 94 | DYRK1B | 0.12934342 |
| 95 | LRRK2 | 0.12609124 |
| 96 | ERN1 | 0.11770089 |
| 97 | RAF1 | 0.11009994 |
| 98 | MARK3 | 0.10394567 |
| 99 | RPS6KA6 | 0.10086726 |
| 100 | FGFR1 | 0.09950048 |
| 101 | MAPK10 | 0.09297720 |
| 102 | PDGFRA | 0.09115224 |
| 103 | FER | 0.08997903 |
| 104 | TYK2 | 0.08101665 |
| 105 | JAK2 | 0.07680925 |
| 106 | GSK3A | 0.07500475 |
| 107 | PTK2B | 0.07242156 |
| 108 | BRAF | 0.07144958 |
| 109 | NLK | 0.06495185 |
| 110 | CCNB1 | 0.06486320 |
| 111 | RET | 0.06004506 |
| 112 | CSNK1D | 0.05757798 |
| 113 | CAMK2A | 0.05532158 |
| 114 | SGK3 | 0.05392538 |
| 115 | PRKACG | 0.05227448 |
| 116 | MTOR | 0.04409088 |
| 117 | KSR1 | 0.04223707 |
| 118 | MAPK8 | 0.04168268 |
| 119 | ROCK2 | 0.04080686 |
| 120 | GSK3B | 0.03345622 |
| 121 | MST1R | 0.03274301 |
| 122 | FGFR3 | 0.03030613 |
| 123 | MAPK3 | 0.02776187 |
| 124 | STK38 | 0.02690506 |
| 125 | RPS6KA1 | 0.02614208 |
| 126 | STK11 | 0.02391738 |
| 127 | PRKCH | 0.01662187 |
| 128 | MAP3K10 | 0.01353401 |
| 129 | MAPK9 | 0.00987968 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.72563732 |
| 2 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.15015700 |
| 3 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.80364466 |
| 4 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.67012820 |
| 5 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.52778467 |
| 6 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.43442036 |
| 7 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.79325108 |
| 8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.78196212 |
| 9 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.62326225 |
| 10 | Carbon metabolism_Homo sapiens_hsa01200 | 2.24621203 |
| 11 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 2.10120552 |
| 12 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 2.02018135 |
| 13 | Insulin signaling pathway_Homo sapiens_hsa04910 | 2.01107167 |
| 14 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.90469992 |
| 15 | Insulin resistance_Homo sapiens_hsa04931 | 1.90081564 |
| 16 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.87104210 |
| 17 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.81136603 |
| 18 | Parkinsons disease_Homo sapiens_hsa05012 | 1.79650213 |
| 19 | Circadian rhythm_Homo sapiens_hsa04710 | 1.70830437 |
| 20 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.66747103 |
| 21 | Alzheimers disease_Homo sapiens_hsa05010 | 1.65577349 |
| 22 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.62745293 |
| 23 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.58110765 |
| 24 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.55422084 |
| 25 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.55403680 |
| 26 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.48825608 |
| 27 | Viral myocarditis_Homo sapiens_hsa05416 | 1.45754882 |
| 28 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.45302878 |
| 29 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.43598346 |
| 30 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.42214336 |
| 31 | Galactose metabolism_Homo sapiens_hsa00052 | 1.41944914 |
| 32 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.41142164 |
| 33 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.19297187 |
| 34 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.15972484 |
| 35 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.12191125 |
| 36 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.10176911 |
| 37 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.06766699 |
| 38 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.01017846 |
| 39 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.00820319 |
| 40 | * Tight junction_Homo sapiens_hsa04530 | 0.99022278 |
| 41 | Focal adhesion_Homo sapiens_hsa04510 | 0.96809768 |
| 42 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.90930170 |
| 43 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.87511789 |
| 44 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.86267532 |
| 45 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.85033259 |
| 46 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.81735929 |
| 47 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.78196195 |
| 48 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.75481608 |
| 49 | Huntingtons disease_Homo sapiens_hsa05016 | 0.74290699 |
| 50 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.72320437 |
| 51 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.70921457 |
| 52 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.69532021 |
| 53 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.69204113 |
| 54 | Renin secretion_Homo sapiens_hsa04924 | 0.67861841 |
| 55 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.67107265 |
| 56 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.60640807 |
| 57 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.58757940 |
| 58 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.58090642 |
| 59 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.56488886 |
| 60 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.54467760 |
| 61 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.53104743 |
| 62 | Insulin secretion_Homo sapiens_hsa04911 | 0.49626881 |
| 63 | Platelet activation_Homo sapiens_hsa04611 | 0.48401598 |
| 64 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.47621435 |
| 65 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.45730625 |
| 66 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.45679885 |
| 67 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.45570483 |
| 68 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.42648770 |
| 69 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.42107642 |
| 70 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.40946831 |
| 71 | Amoebiasis_Homo sapiens_hsa05146 | 0.39254630 |
| 72 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.37480941 |
| 73 | Salivary secretion_Homo sapiens_hsa04970 | 0.36583497 |
| 74 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.35320988 |
| 75 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.32863822 |
| 76 | Histidine metabolism_Homo sapiens_hsa00340 | 0.31910713 |
| 77 | Lysine degradation_Homo sapiens_hsa00310 | 0.30735652 |
| 78 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.30194172 |
| 79 | Adherens junction_Homo sapiens_hsa04520 | 0.30050556 |
| 80 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.28495981 |
| 81 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.27999119 |
| 82 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.27445277 |
| 83 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.26452962 |
| 84 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.26117249 |
| 85 | Long-term depression_Homo sapiens_hsa04730 | 0.25682966 |
| 86 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.24841180 |
| 87 | Peroxisome_Homo sapiens_hsa04146 | 0.24618730 |
| 88 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.23198455 |
| 89 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.21372657 |
| 90 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.21273820 |
| 91 | Glioma_Homo sapiens_hsa05214 | 0.20816585 |
| 92 | Purine metabolism_Homo sapiens_hsa00230 | 0.20679457 |
| 93 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.20157296 |
| 94 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.19015965 |
| 95 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.17174240 |
| 96 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.16885885 |
| 97 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.15282413 |
| 98 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.15051970 |
| 99 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.14539904 |
| 100 | Thyroid cancer_Homo sapiens_hsa05216 | 0.14332695 |
| 101 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.14212209 |
| 102 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.13559201 |
| 103 | Melanogenesis_Homo sapiens_hsa04916 | 0.12751566 |
| 104 | Circadian entrainment_Homo sapiens_hsa04713 | 0.12729185 |
| 105 | Bile secretion_Homo sapiens_hsa04976 | 0.12652569 |
| 106 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.11243772 |
| 107 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.10416882 |
| 108 | ABC transporters_Homo sapiens_hsa02010 | 0.10228541 |
| 109 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.09774613 |
| 110 | Long-term potentiation_Homo sapiens_hsa04720 | 0.08420298 |
| 111 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.07761640 |
| 112 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.07522300 |
| 113 | Metabolic pathways_Homo sapiens_hsa01100 | 0.07206731 |
| 114 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.06449162 |
| 115 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.06393384 |
| 116 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.06252717 |
| 117 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.02627941 |

